Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone
- 1 September 2015
- journal article
- clinical trial
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 19 (5) , 547-552
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Thiamine transporter-2 deficiency: outcome and treatment monitoringOrphanet Journal of Rare Diseases, 2014
- Stress‐Induced Upregulation of SLC19A3 is Impaired in Biotin‐Thiamine‐Responsive Basal Ganglia DiseaseBrain Pathology, 2014
- Biotin-responsive basal ganglia disease revisitedNeurology, 2013
- Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new casesOrphanet Journal of Rare Diseases, 2013
- Biotin-Responsive Basal Ganglia Disease in Ethnic Europeans With Novel SLC19A3 MutationsArchives of Neurology, 2010
- Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot studyThe Lancet Neurology, 2009
- Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2American Journal of Physiology-Cell Physiology, 2006
- Biotin-Responsive Basal Ganglia Disease Maps to 2q36.3 and Is Due to Mutations in SLC19A3The American Journal of Human Genetics, 2005
- Biotin-responsive basal ganglia disease: a novel entityBrain, 1998
- Validity and reliability of a rating scale for the primary torsion dystoniasNeurology, 1985